Actively Recruiting
Incidence, Associated Factors, and Burden of Post COVID-19 Condition in Brazil
Led by Inova Medical · Updated on 2025-02-19
1694
Participants Needed
1
Research Sites
105 weeks
Total Duration
On this page
Sponsors
I
Inova Medical
Lead Sponsor
M
Merck Sharp & Dohme LLC
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a national retrospective cohort study with internet-based recruitment which intends to enroll 1,694 adult patients with COVID-19 diagnosis during the SARS-CoV-2 omicron wave in Brazil. Participants with confirmed symptomatic COVID-19 after january 2022 will be evaluated in order to assess incidence, potential risk factors and impact of post COVID-19 condition according to the WHO definition on health-related quality of life and other relevant patient-centered outcomes.
CONDITIONS
Official Title
Incidence, Associated Factors, and Burden of Post COVID-19 Condition in Brazil
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years
- Brazilian resident
- Symptomatic COVID-19 confirmed by reverse transcriptase polymerase chain reaction (RT-PCR) or antigen test for SARS-COV-2 after January 2022, with diagnosis at least 90 days before recruitment
You will not qualify if you...
- No availability to participate in remote research appointments
- Communication difficulty (aphasia, important hearing loss, non-portuguese speaker, severe dementia)
- Refuse to provide informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Inova Medical
Cachoeirinha, Rio Grande do Sul, Brazil
Actively Recruiting
Research Team
M
Maicon Falavigna, MD, PhD
CONTACT
R
Régis G Rosa, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here